Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Oct;55(10):2383–2386. doi: 10.1128/iai.55.10.2383-2386.1987

Comparative analysis of the localization of lipoteichoic acid in Streptococcus agalactiae and Streptococcus pyogenes.

S J Mattingly 1, B P Johnston 1
PMCID: PMC260717  PMID: 3308704

Abstract

The cellular locations of deacylated lipoteichoic acid (dLTA) and lipoteichoic acid (LTA) were examined in late-exponential-phase cells of a serotype III strain of Streptococcus agalactiae (group B streptococci [GBS]) isolated from an infant with late-onset meningitis and compared with a fresh clinical isolate of Streptococcus pyogenes (group A streptococci [GAS]). LTA and dLTA were found to be associated with the protoplast membranes of both organisms, with only dLTA found in mutanolysin cell wall digests. Both organisms released dLTA during growth, but only the GAS released substantial levels of LTA into the culture medium. However, penicillin treatment (5 micrograms/ml for 60 min) of GBS resulted in the recovery of LTA in cell wall digests as well as in the culture medium. These results suggest that under normal growth conditions, the hydrophobic region (glycolipid) of LTA remains associated with the cytoplasmic membrane of GBS and unavailable for hydrophobic interactions at the cell surface with epithelial cells. In contrast, release of LTA into the environment by the GAS allows the fatty acid moieties to interact with hydrophobic domains on the surface of epithelial cells. These results may help explain the marked differences in the specificity of binding between these two major streptococcal pathogens for human fetal and adult epithelial cells.

Full text

PDF
2386

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkan M. L., Beachey E. H. Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest. 1978 Mar;61(3):671–677. doi: 10.1172/JCI108979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boyer K. M., Gotoff S. P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986 Jun 26;314(26):1665–1669. doi: 10.1056/NEJM198606263142603. [DOI] [PubMed] [Google Scholar]
  3. Doran T. I., Mattingly S. J. Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus. Infect Immun. 1982 Jun;36(3):1115–1122. doi: 10.1128/iai.36.3.1115-1122.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Horne D., Tomasz A. Release of lipoteichoic acid from Streptococcus sanguis: stimulation of release during penicillin treatment. J Bacteriol. 1979 Mar;137(3):1180–1184. doi: 10.1128/jb.137.3.1180-1184.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Iwasaki H., Shimada A., Ito E. Comparative studies of lipoteichoic acids from several Bacillus strains. J Bacteriol. 1986 Aug;167(2):508–516. doi: 10.1128/jb.167.2.508-516.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Milligan T. W., Doran T. I., Straus D. C., Mattingly S. J. Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol. 1978 Jan;7(1):28–33. doi: 10.1128/jcm.7.1.28-33.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nealon T. J., Mattingly S. J. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease. Infect Immun. 1983 Mar;39(3):1243–1251. doi: 10.1128/iai.39.3.1243-1251.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nealon T. J., Mattingly S. J. Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci. Infect Immun. 1985 Oct;50(1):107–115. doi: 10.1128/iai.50.1.107-115.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nealon T. J., Mattingly S. J. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells. Infect Immun. 1984 Feb;43(2):523–530. doi: 10.1128/iai.43.2.523-530.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ofek I., Beachey E. H., Eyal F., Morrison J. C. Postnatal development of binding of streptococci and lipoteichoic acid by oral mucosal cells of humans. J Infect Dis. 1977 Feb;135(2):267–274. doi: 10.1093/infdis/135.2.267. [DOI] [PubMed] [Google Scholar]
  11. Ofek I., Simpson W. A., Beachey E. H. Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol. 1982 Feb;149(2):426–433. doi: 10.1128/jb.149.2.426-433.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yeung M. K., Mattingly S. J. Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus. J Bacteriol. 1983 Apr;154(1):211–220. doi: 10.1128/jb.154.1.211-220.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES